UPDATE 1-Sanofi says Jevtana improves prostate cancer survival | Reuters
Links shared publicly online about this topic.
- 834total visits
UPDATE 1-Sanofi says Jevtana improves prostate cancer survival | Reuters
* Phase III data shows Jevtana improves survival rate * Data used as basis for FDA approval of Jevtana in June (Adds details from statement) PARIS, Oct 1 (Reuters) - Sanofi-Aventis ,
View full resource at reuters.com
Tags: Cancer, Prostate Cancer, Prostate, Men's Health, FDA, Sanofi-Aventis, Jevtana
Most Recently Shared on October 1, 2010 at 6:12 am By:
Sanofi says Jevtana improves prostate cancer survival http://bit.ly/azFlP2
Advertisement
